AuntMinnie
JUNE 8, 2024
TORONTO -- AuntMinnie.com spoke with cardiac PET imaging expert Krishna Patel, MD, from Mount Sinai in New York City, at the Society of Nuclear Medicine and Molecular Imaging annual meeting. She discussed what’s termed ischemia with non-obstructive coronary arteries (INOCA) and how new PET radiotracers may be a game changer in treating the condition.
Diagnostic Imaging
JUNE 8, 2024
The use of 90Y-FAPI-46 radioligand therapy resulted in controlled disease progression in nearly half of a 30-person cohort largely comprised of patients with advanced sarcomas, according to new research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
JUNE 8, 2024
An emerging PET/CT radiotracer may be more predictive of progressive pulmonary fibrosis in interstitial lung patients than F-18 FDG PET/CT, according to research presented June 8 at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI). Fibroblast activation protein inhibitor (FAPI) PET/CT demonstrated heightened and extensive uptake in interstitial lung disease (ILD) compared to FDG in a cohort of 97 patients with ILD.
Diagnostic Imaging
JUNE 8, 2024
For patients with interstitial lung disease, FAPI PET/CT was more effective than 18F-FDG PET/CT at predicting progressive pulmonary fibrosis according to comparative study findings presented at the 2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting.
Advertisement
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
AuntMinnie
JUNE 8, 2024
An emerging radioligand therapy could be particularly effective for controlling advanced sarcoma compared to other cancers, according to research presented June 8 in a Young Investigator Award session at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Toronto. This yttrium-90 (Y-90)-labeled fibroblast activation protein inhibitor (FAPI)-46 research comes from Helena Lanzafame, MD, and colleagues from the department of nuclear medicine at University Hospital Essen in Germ
Diagnostic Imaging Brief brings together the best content for architecture professionals from the widest variety of industry thought leaders.
Diagnostic Imaging
JUNE 8, 2024
In addition to new advances in PET/CT imaging to facilitate precision imaging, the company will also unveil a device at the SNMMI conference that allows in-house production of commercial PET tracers.
AuntMinnie
JUNE 8, 2024
Cybil Nielsen has been elected as the 2024-2025 president-elect for the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Technologist Section. Cybil Nielsen of Gurnick Academy of Medical Arts in Concord, CA. Image courtesy of SNMMI. Nielsen, a nuclear medicine educator at Gurnick Academy of Medical Arts in Concord, CA, was among a new slate of officers introduced June 9 during the SNMMI’s annual meeting in Toronto.
Open Medscience
JUNE 8, 2024
Ongoing Alzheimer's research is crucial for developing early detection methods, effective treatments, and comprehensive caregiver support. The post Understanding the Importance of Ongoing Alzheimer’s Research appeared first on Open MedScience.
Diagnostic Imaging
JUNE 8, 2024
Catch up on the top radiology content of the past week.
ScienceDirect
JUNE 8, 2024
A number of studies have reported that contrast-enhanced ultrasound (CEUS) imaging might be used for the early diagnosis of adnexal masses.
Expert insights. Personalized for you.
111 
Let's personalize your content